Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.935
+0.105 (2.74%)
Jul 21, 2026, 10:06 AM EDT - Market open
Larimar Therapeutics Employees
Larimar Therapeutics had 71 employees as of December 31, 2025. The number of employees increased by 6 or 9.23% compared to the previous year.
Employees
71
Change (1Y)
6
Growth (1Y)
9.23%
Revenue / Employee
n/a
Profits / Employee
-$2,338,099
Market Cap
410.75M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 71 | 6 | 9.23% |
| Dec 31, 2024 | 65 | 23 | 54.76% |
| Dec 31, 2023 | 42 | 16 | 61.54% |
| Dec 31, 2022 | 26 | -5 | -16.13% |
| Dec 31, 2021 | 31 | 3 | 10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Atea Pharmaceuticals | 55 |
| Inhibikase Therapeutics | 35 |
LRMR News
- 12 days ago - Larimar Therapeutics director buys $167K in common stock - TheFly
- 19 days ago - Larimar Therapeutics assumed with a Buy at H.C. Wainwright - TheFly
- 21 days ago - Larimar Therapeutics price target lowered to $5 from $7 at Baird - TheFly
- 21 days ago - Larimar Therapeutics selloff a buying opportunity, says Citi - TheFly
- 21 days ago - Larimar stumbles on safety news even as BLA submission kicks off - TheFly
- 22 days ago - Larimar Therapeutics Transcript: Study update - Transcripts
- 22 days ago - Larimar Therapeutics Press release: Study update - Filings
- 22 days ago - Larimar Therapeutics Slides: Study update - Filings